Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Nat Med 30 , 20492057 (2024)
Outcomes vary
Trial participants on the highest dose lost roughly 15% of body weight over 68 weeks, a number so far above what any prior pharmacotherapy had achieved that endocrinologists who had spent careers managing modest expectations had to recalibrate the conversation in real time
The most frequently reported include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation
For a detailed dose-by-dose comparison, see the retatrutide versus tirzepatide dosage chart and the full comparison guide
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
